Patents by Inventor Anat Eitan

Anat Eitan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPLEMENT C3a DERIVED DIMERIC PEPTIDES AND USES THEREOF
    Publication number: 20110306561
    Abstract: Peptide compositions comprising a dimeric peptide which combines two peptide monomers, each independently comprising the amino acid sequence: Asp-X1-X2-Asn-Tyr-Ile-Thr-X3 wherein: X1 is selected from the group consisting of Cys and a Cys derivative; X2 is selected from the group consisting of Cys and a Cys derivative; and X3 is selected from the group consisting of Arg and Glu-Leu-Arg, provided that at least one of X1 and X2 is Cys, whereby a mol percentage of the dimeric peptide in the composition is at least 50 mol percents, or at least 99 mol percents, are disclosed. Further disclosed are processes of preparing such peptide compositions and uses thereof in the treatment of allergic disorders.
    Type: Application
    Filed: February 11, 2010
    Publication date: December 15, 2011
    Applicant: Yeda Research And Devlopment Co. Ltd.
    Inventors: Israel Pecht, Anna Erdei, Anat Eitan
  • Composition for topical treatment of psoriasis and atopic dermatitis comprising a xanthine derivative
    Patent number: 5565462
    Abstract: Use of a compound selected from the group consisting of pentoxifylline, propentofylline and torbafylline for topical treatment of psoriasis or atopic dermatitis and pharmaceutical compositions comprising them.
    Type: Grant
    Filed: June 21, 1994
    Date of Patent: October 15, 1996
    Assignees: Teva Pharmaceutical Industries, Ltd., Ramot University for Applied Research and Industrial Development, Ltd.
    Inventors: Anat Eitan, Rachel Nachman, Sasson Cohen